Biosensor developments: application to prostate-specific antigen detection - PubMed (original) (raw)
Review
Biosensor developments: application to prostate-specific antigen detection
Declan A Healy et al. Trends Biotechnol. 2007 Mar.
Abstract
Prostate-specific antigen (PSA) is the best serum marker currently available for the detection of prostate cancer and is the forensic marker of choice for determining the presence of azoospermic semen in some sexual assault cases. Most current assays for PSA detection are processed on large analyzers at dedicated testing sites, which require that samples be sent away for testing. This leads to delays in patient management and increased administration costs. The recent emphasis placed on the need for point-of-care patient management has led to the development of novel biosensor detection strategies that are suitable for the miniaturization of assays for various targets including PSA. This review highlights the current and novel analytical technologies used for PSA detection, which will benefit clinicians, patients and forensic workers in the future.
Similar articles
- Evaluation of prostate-specific antigen (PSA) membrane test assays for the forensic identification of seminal fluid.
Hochmeister MN, Budowle B, Rudin O, Gehrig C, Borer U, Thali M, Dirnhofer R. Hochmeister MN, et al. J Forensic Sci. 1999 Sep;44(5):1057-60. J Forensic Sci. 1999. PMID: 10486959 - Validation of the use of a commercially available kit for the identification of prostate specific antigen (PSA) in semen stains.
Simich JP, Morris SL, Klick RL, Rittenhouse-Diakun K. Simich JP, et al. J Forensic Sci. 1999 Nov;44(6):1229-31. J Forensic Sci. 1999. PMID: 10582360 - Prostate-specific antigen kinetics in localized and advanced prostate cancer.
Fitzpatrick JM, Banu E, Oudard S. Fitzpatrick JM, et al. BJU Int. 2009 Mar;103(5):578-87. doi: 10.1111/j.1464-410X.2009.08345.x. Epub 2009 Feb 6. BJU Int. 2009. PMID: 19210674 Review. - New molecular biomarkers for the prognosis and management of prostate cancer--the post PSA era.
Bickers B, Aukim-Hastie C. Bickers B, et al. Anticancer Res. 2009 Aug;29(8):3289-98. Anticancer Res. 2009. PMID: 19661347 Review.
Cited by
- Graphene/MoS2 Nanohybrid for Biosensors.
Choi JW, Yoon J, Lim J, Shin M, Lee SN. Choi JW, et al. Materials (Basel). 2021 Jan 21;14(3):518. doi: 10.3390/ma14030518. Materials (Basel). 2021. PMID: 33494525 Free PMC article. Review. - Evaluation of the Spectral Response of Functionalized Silk Inverse Opals as Colorimetric Immunosensors.
Burke KA, Brenckle MA, Kaplan DL, Omenetto FG. Burke KA, et al. ACS Appl Mater Interfaces. 2016 Jun 29;8(25):16218-26. doi: 10.1021/acsami.6b02215. Epub 2016 Jun 20. ACS Appl Mater Interfaces. 2016. PMID: 27322909 Free PMC article. - Arraying prostate specific antigen PSA and Fab anti-PSA using light-assisted molecular immobilization technology.
Parracino A, Neves-Petersen MT, di Gennaro AK, Pettersson K, Lövgren T, Petersen SB. Parracino A, et al. Protein Sci. 2010 Sep;19(9):1751-9. doi: 10.1002/pro.461. Protein Sci. 2010. PMID: 20665692 Free PMC article. - Nanomedicine: barcodes check out prostate cancer.
Hearty S, Leonard P, O'Kennedy R. Hearty S, et al. Nat Nanotechnol. 2010 Jan;5(1):9-10. doi: 10.1038/nnano.2009.459. Nat Nanotechnol. 2010. PMID: 20032981 No abstract available. - Recent Advances in 3D Printing of Biomedical Sensing Devices.
Ali MA, Hu C, Yttri EA, Panat R. Ali MA, et al. Adv Funct Mater. 2022 Feb 23;32(9):2107671. doi: 10.1002/adfm.202107671. Epub 2021 Nov 25. Adv Funct Mater. 2022. PMID: 36324737 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous